Epoch Biodesign Raises $18.3M in Series A Funding
Deal News | Mar 06, 2025 | Goodwin
Epoch Biodesign, a UK-based startup, has successfully raised $18.3 million in an oversubscribed Series A funding round. Established in 2019, the company was founded by Jacob Nathans after his high school science project on the use of enzymes to break down plastic waste. With a growing team of over 30 professionals, Epoch is focused on expanding the production of its innovative plastic-eating enzymes. The funding will be used to transition the biorecycling process from the laboratory to a production facility, marking a significant milestone for the company. The Series A round was spearheaded by the climate-centred investment firm Extantia Capital, alongside participants such as Day One Ventures, Happiness Capital, Kibo Invest, and Lowercarbon Capital. Additionally, Mundi Ventures facilitated a strategic investment from Inditex, the major Spanish fast fashion entity that owns Zara. Legal advisory services for Epoch Biodesign during this transaction were provided by the London and Cambridge Technology team at Goodwin, with Adam Thatcher and Duy Le leading the effort.
Sectors
- Biotechnology
- Climate Technology
- Fashion and Apparel
Geography
- United Kingdom – Epoch Biodesign is headquartered in the UK, specifically in London and Cambridge.
- Spain – Inditex, a strategic investor in this funding round, is based in Spain.
Industry
- Biotechnology – Epoch Biodesign operates in the biotechnology sector, focusing on developing enzymes for biorecycling plastic waste.
- Climate Technology – The funding round was led by Extantia Capital, a climate-focused investor, emphasizing the environmental impact of Epoch Biodesign's technology.
- Fashion and Apparel – Inditex, a major player in the fast fashion industry, invested strategically through Mundi Ventures, indicating an intersection with the fashion sector.
Financials
- $18.3 million – The total amount raised by Epoch Biodesign in their Series A funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Epoch Biodesign | Target Company | Company | A UK-based startup specializing in enzyme technology for breaking down plastic waste. |
| Extantia Capital | Lead Investor | Company | A climate-focused investment firm that led the Series A funding round. |
| Inditex | Strategic Investor | Company | A Spanish fast fashion giant and owner of Zara, investing through Mundi Ventures. |
| Goodwin | Legal Advisor | Company | Provided legal advice to Epoch Biodesign, led by Adam Thatcher and Duy Le. |